Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Literature
1.
Tanaka M, Fernández-del Castillo C, Adsay V et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatol Off J Int Assoc Pancreatol IAP Al 2012;12:183–197.
2.
Tanaka M, Fernández-Del Castillo C, Kamisawa T et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatol Off J Int Assoc Pancreatol IAP Al 2017;17:738–753.
3.
European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018;67:789–804.CrossRef
4.
Vege SS, Ziring B, Jain R, et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 2015; 148: 819–822; quize12–13.
5.
Scheiman JM, Hwang JH, Moayyedi P. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 2015;148:824-848.e22.PubMedCrossRef
6.
Elta GH, Enestvedt BK, Sauer BG et al. ACG clinical guideline: diagnosis and management of pancreatic cysts. Am J Gastroenterol 2018;113:464–479.PubMedCrossRef
7.
Megibow AJ, Baker ME, Morgan DE et al. Management of incidental pancreatic cysts: a white paper of the ACR incidental findings committee. J Am Coll Radiol JACR 2017;14:911–923.PubMedCrossRef
8.
de Jong K, Nio CY, Hermans JJ et al. High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2010;8:806–811.
9.
Lee KS, Sekhar A, Rofsky NM et al. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol 2010;105:2079–2084.PubMedCrossRef
10.
Canakis A, Law R, Baron T. An updated review on ablative treatment of pancreatic cystic lesions. Gastrointest Endosc 2020;91:520–526.PubMedCrossRef
11.
Kimura W, Nagai H, Kuroda A et al. Analysis of small cystic lesions of the pancreas. Int J Pancreatol Off J Int Assoc Pancreatol 1995;18:197–206.CrossRef
12.
Abdelkader A, Hunt B, Hartley CP et al. Cystic lesions of the pancreas: differential diagnosis and cytologic-histologic correlation. Arch Pathol Lab Med 2020;144:47–61.PubMedCrossRef
13.
Jais B, Rebours V, Malleo G et al. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut 2016;65:305–312.PubMedCrossRef
14.
Crippa S, Salvia R, Warshaw AL et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 2008;247:571–579.PubMedCrossRef
15.
Park JW, Jang J-Y, Kang MJ et al. Mucinous cystic neoplasm of the pancreas: is surgical resection recommended for all surgically fit patients? Pancreatol Off J Int Assoc Pancreatol IAP Al 2014;14:131–136.
16.
van Huijgevoort NCM, Del Chiaro M, Wolfgang CL et al. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines. Nat Rev Gastroenterol Hepatol 2019;16:676–689.PubMedCrossRef
17.
Jang K-T, Park SM, Basturk O et al. Clinicopathologic characteristics of 29 invasive carcinomas arising in 178 pancreatic mucinous cystic neoplasms with ovarian-type stroma. Am J Surg Pathol 2015;39:179–187.PubMedPubMedCentralCrossRef
18.
Gil E, Choi SH, Choi DW et al. Mucinous cystic neoplasms of the pancreas with ovarian stroma. ANZ J Surg 2013;83:985–990.PubMedCrossRef
19.
Sahora K, Fernández-del Castillo C, Dong F et al. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: Implications of minimal involvement of the main pancreatic duct. Surgery 2014;156:611–621.PubMedCrossRef
20.
Crippa S, Bassi C, Salvia R et al. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis. Gut 2017;66:495–506.PubMedCrossRef
21.
Pergolini I, Schorn S, Jäger C et al. Diabetes mellitus in intraductal papillary mucinous neoplasms: a systematic review and meta-analysis. Surgery 2021;169:411–418.PubMedCrossRef
22.
Maggi G, Guarneri G, Gasparini G et al. Pancreatic cystic neoplasms: what is the most cost-effective follow-up strategy? Endosc Ultrasound 2018;7:319–322.PubMedPubMedCentralCrossRef
23.
Jones MJ, Buchanan AS, Neal CP et al. Imaging of indeterminate pancreatic cystic lesions: a systematic review. Pancreatol Off J Int Assoc Pancreatol IAP Al 2013;13:436–442.
24.
Expert Panel on Gastrointestinal Imaging, Fábrega-Foster K, Kamel IR, et al. ACR Appropriateness Criteria® Pancreatic Cyst. J Am Coll Radiol JACR 2020; 17: S198–S206.
25.
Sainani NI, Saokar A, Deshpande V et al. Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts. AJR Am J Roentgenol 2009;193:722–731.PubMedCrossRef
26.
Runge VM. Critical questions regarding gadolinium deposition in the brain and body after injections of the gadolinium-based contrast agents, safety, and clinical recommendations in consideration of the EMA’s Pharmacovigilance and risk assessment committee recommendation for suspension of the marketing authorizations for 4 linear agents. Invest Radiol 2017;52:317–323.PubMedCrossRef
27.
Macari M, Lee T, Kim S et al. Is gadolinium necessary for MRI follow-up evaluation of cystic lesions in the pancreas? Preliminary results. AJR Am J Roentgenol 2009;192:159–164.PubMedCrossRef
28.
Rastegar N, Matteoni-Athayde LG, Eng J et al. Incremental value of secretin-enhanced magnetic resonance cholangiopancreatography in detecting ductal communication in a population with high prevalence of small pancreatic cysts. Eur J Radiol 2015;84:575–580.PubMedPubMedCentralCrossRef
29.
30.
Srinivasan N, Koh Y-X, Goh BKP. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas. Surgery 2019;165:929–937.PubMedCrossRef
31.
Kauhanen S, Rinta-Kiikka I, Kemppainen J et al. Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR imaging in the diagnosis of pancreatic cysts: a prospective single-center study. J Nucl Med Off Publ Soc Nucl Med 2015;56:1163–1168.
32.
Visser BC, Yeh BM, Qayyum A et al. Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. AJR Am J Roentgenol 2007;189:648–656.PubMedCrossRef
33.
Brugge WR, Lewandrowski K, Lee-Lewandrowski E et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004;126:1330–1336.PubMedCrossRef
34.
Zhong N, Zhang L, Takahashi N et al. Histologic and imaging features of mural nodules in mucinous pancreatic cysts. Clin Gastroenterol Hepatol 2012;10:192-198.e2.PubMedCrossRef
35.
Kamata K, Kitano M, Omoto S et al. Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy 2016;48:35–41.PubMed
36.
Yamamoto N, Kato H, Tomoda T et al. Contrast-enhanced harmonic endoscopic ultrasonography with time-intensity curve analysis for intraductal papillary mucinous neoplasms of the pancreas. Endoscopy 2016;48:26–34.PubMed
37.
Marchegiani G, Andrianello S, Borin A et al. Systematic review, meta-analysis, and a high-volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas. Surgery 2018;163:1272–1279.PubMedCrossRef
38.
Ohno E, Kawashima H, Ishikawa T et al. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms? Pancreatol Off J Int Assoc Pancreatol IAP Al 2020;20:887–894.
39.
Bick BL, Enders FT, Levy MJ et al. The string sign for diagnosis of mucinous pancreatic cysts. Endoscopy 2015;47:626–631.PubMedCrossRef
40.
Lee LS, Saltzman JR, Bounds BC et al. EUS-guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2005;3:231–236.
41.
Wang K-X, Ben Q-W, Jin Z-D et al. Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. Gastrointest Endosc 2011;73:283–290.PubMedCrossRef
42.
Colán-Hernández J, Sendino O, Loras C et al. Antibiotic prophylaxis is not required for endoscopic ultrasonography-guided fine-needle aspiration of pancreatic cystic lesions. Based on a Randomized Trial. Gastroenterology 2020;158:1642-1649.e1.PubMed
43.
Khashab MA, Chithadi KV, Acosta RD et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2015;81:81–89.PubMedCrossRef
44.
Suzuki R, Thosani N, Annangi S et al. Diagnostic yield of EUS-FNA-based cytology distinguishing malignant and benign IPMNs: a systematic review and meta-analysis. Pancreatol Off J Int Assoc Pancreatol IAP Al 2014;14:380–384.
45.
Thornton GD, McPhail MJW, Nayagam S et al. Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: a meta-analysis. Pancreatol Off J Int Assoc Pancreatol IAP Al 2013;13:48–57.
46.
Thosani N, Thosani S, Qiao W et al. Role of EUS-FNA based cytology in diagnosis of mucinous pancreatic cystic lesions: a systematic review and meta-analysis. Dig Dis Sci 2010;55:2756–2766.PubMedPubMedCentralCrossRef
47.
de Jong K, Poley J-W, van Hooft JE et al. Endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions provides inadequate material for cytology and laboratory analysis: initial results from a prospective study. Endoscopy 2011;43:585–590.PubMedCrossRef
48.
Hong S-KS, Loren DE, Rogart JN et al. Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield of premalignant and malignant pancreatic cysts. Gastrointest Endosc 2012;75:775–782.PubMedCrossRef
49.
Phan J, Dawson D, Sedarat A et al. Clinical utility of obtaining endoscopic ultrasound-guided fine-needle biopsies for histologic analyses of pancreatic cystic lesions. Gastroenterology 2020;158:475-477.e1.PubMedCrossRef
50.
van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc 2005;62:383–389.PubMedCrossRef
51.
52.
Carr RA, Yip-Schneider MT, Simpson RE et al. Pancreatic cyst fluid glucose: rapid, inexpensive, and accurate diagnosis of mucinous pancreatic cysts. Surgery 2018;163:600–605.PubMedCrossRef
53.
Faias S, Pereira L, Roque R et al. Excellent accuracy of glucose level in cystic fluid for diagnosis of pancreatic mucinous cysts. Dig Dis Sci 2020;65:2071–2078.PubMedCrossRef
54.
Ribaldone DG, Bruno M, Gaia S et al. Differential diagnosis of pancreatic cysts: a prospective study on the role of intra-cystic glucose concentration. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver 2020;52:1026–1032.
55.
Simons-Linares CR, Yadav D, Lopez R et al. The utility of intracystic glucose levels in differentiating mucinous from non-mucinous pancreatic cysts. Pancreatol Off J Int Assoc Pancreatol IAP Al 2020;20:1386–1392.
56.
Springer S, Wang Y, Molin MD et al. A combination of molecular markers and clinical features improve the classification of pancreatic cysts. Gastroenterology 2015;149:1501–1510.PubMedCrossRef
57.
Lee A, Kadiyala V, Lee LS. Evaluation of AGA and fukuoka guidelines for EUS and surgical resection of incidental pancreatic cysts. Endosc Int Open 2017;5:E116–E122.PubMedPubMedCentralCrossRef
58.
Singhi AD, Zeh HJ, Brand RE et al. American gastroenterological association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data. Gastrointest Endosc 2016;83:1107-1117.e2.PubMedCrossRef
59.
Singhi AD, McGrath K, Brand RE et al. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. Gut 2018;67:2131–2141.PubMedCrossRef
60.
Nikiforova MN, Khalid A, Fasanella KE, et al. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts. Mod Pathol Off J U S Can Acad Pathol Inc 2013; 26: 1478–1487.
61.
Jimenez RE, Warshaw AL, Z’graggen K, et al. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann Surg 1999; 230: 501–509; discussion 509–511.
62.
63.
Shibata H, Ohike N, Norose T et al. Mucinous cystic neoplasms lined by abundant mucinous epithelium frequently involve KRAS mutations and malignant progression. Anticancer Res 2017;37:7063–7068.PubMed
64.
Wu J, Jiao Y, Dal Molin M et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A 2011;108:21188–21193.PubMedPubMedCentralCrossRef
65.
Aparicio JR, Martínez J, Niveiro M et al. Direct intracystic biopsy and pancreatic cystoscopy through a 19-gauge needle EUS (with videos). Gastrointest Endosc 2010;72:1285–1288.PubMedCrossRef
66.
Crinò SF, Bernardoni L, Brozzi L et al. Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions. Gastrointest Endosc 2019;90:933–943.PubMedCrossRef
67.
Larghi A, Manfrin E, Fabbri C et al. Interobserver agreement among expert pathologists on through-the-needle microforceps biopsy samples for evaluation of pancreatic cystic lesions. Gastrointest Endosc 2019;90:784-792.e4.PubMedCrossRef
68.
Tacelli M, Celsa C, Magro B et al. Diagnostic performance of endoscopic ultrasound through-the-needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta-analysis. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2020. https://​doi.​org/​10.​1111/​den.​13626.CrossRef
69.
Nakai Y, Isayama H, Chang KJ et al. A pilot study of EUS-guided through-the-needle forceps biopsy (with video). Gastrointest Endosc 2016;84:158–162.PubMedCrossRef
70.
Shakhatreh MH, Naini SR, Brijbassie AA et al. Use of a novel through-the-needle biopsy forceps in endoscopic ultrasound. Endosc Int Open 2016;4:E439–E442.PubMedPubMedCentralCrossRef
71.
Kovacevic B, Karstensen JG, Havre RF et al. Initial experience with EUS-guided microbiopsy forceps in diagnosing pancreatic cystic lesions: A multicenter feasibility study (with video). Endosc Ultrasound 2018;7:383–388.PubMedPubMedCentralCrossRef
72.
Barresi L, Crinò SF, Fabbri C et al. Endoscopic ultrasound-through-the-needle biopsy in pancreatic cystic lesions: a multicenter study. Dig Endosc Off J Jpn Gastroenterol Endosc Soc 2018;30:760–770.
73.
Basar O, Yuksel O, Yang DJ et al. Feasibility and safety of microforceps biopsy in the diagnosis of pancreatic cysts. Gastrointest Endosc 2018;88:79–86.PubMedCrossRef
74.
Mittal C, Obuch JC, Hammad H et al. Technical feasibility, diagnostic yield, and safety of microforceps biopsies during EUS evaluation of pancreatic cystic lesions (with video). Gastrointest Endosc 2018;87:1263–1269.PubMedCrossRef
75.
Yang D, Samarasena JB, Jamil LH et al. Endoscopic ultrasound-guided through-the-needle microforceps biopsy in the evaluation of pancreatic cystic lesions: a multicenter study. Endosc Int Open 2018;6:E1423–E1430.PubMedPubMedCentralCrossRef
76.
Yang D, Trindade AJ, Yachimski P et al. Histologic analysis of endoscopic ultrasound-guided through the needle microforceps biopsies accurately identifies mucinous pancreas cysts. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2019;17:1587–1596.
77.
Westerveld DR, Ponniah SA, Draganov PV et al. Diagnostic yield of EUS-guided through-the-needle microforceps biopsy versus EUS-FNA of pancreatic cystic lesions: a systematic review and meta-analysis. Endosc Int Open 2020;8:E656–E667.PubMedPubMedCentralCrossRef
78.
Zhang ML, Arpin RN, Brugge WR et al. Moray micro forceps biopsy improves the diagnosis of specific pancreatic cysts. Cancer Cytopathol 2018;126:414–420.PubMedCrossRef
79.
Kovacevic B, Klausen P, Hasselby JP et al. A novel endoscopic ultrasound-guided through-the-needle microbiopsy procedure improves diagnosis of pancreatic cystic lesions. Endoscopy 2018;50:1105–1111.PubMedCrossRef
80.
Lakhtakia S, Ramchandani M, Galasso D et al. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos). Gastrointest Endosc 2016;83:234–239.PubMedCrossRef
81.
82.
Durkin C, Krishna SG. Advanced diagnostics for pancreatic cysts: Confocal endomicroscopy and molecular analysis. World J Gastroenterol 2019;25:2734–2742.PubMedPubMedCentralCrossRef
83.
Alvarez-Sánchez M-V, Napoléon B. New horizons in the endoscopic ultrasonography-based diagnosis of pancreatic cystic lesions. World J Gastroenterol 2018;24:2853–2866.PubMedPubMedCentralCrossRef
84.
Facciorusso A, Buccino VR, Sacco R. Needle-based confocal laser endomicroscopy in pancreatic cysts: a meta-analysis. Eur J Gastroenterol Hepatol 2020;32:1084–1090.PubMedCrossRef
85.
Napoleon B, Krishna SG, Marco B et al. Confocal endomicroscopy for evaluation of pancreatic cystic lesions: a systematic review and international Delphi consensus report. Endosc Int Open 2020;8:E1566–E1581.PubMedPubMedCentralCrossRef
86.
Konda VJA, Meining A, Jamil LH et al. A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance. Endoscopy 2013;45:1006–1013.PubMedCrossRef
87.
Napoleon B, Lemaistre A-I, Pujol B et al. In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (nCLE): proposition of a comprehensive nCLE classification confirmed by an external retrospective evaluation. Surg Endosc 2016;30:2603–2612.PubMedCrossRef
88.
Napoléon B, Lemaistre A-I, Pujol B et al. A novel approach to the diagnosis of pancreatic serous cystadenoma: needle-based confocal laser endomicroscopy. Endoscopy 2015;47:26–32.PubMed
89.
Napoleon B, Palazzo M, Lemaistre A-I et al. Needle-based confocal laser endomicroscopy of pancreatic cystic lesions: a prospective multicenter validation study in patients with definite diagnosis. Endoscopy 2019;51:825–835.PubMedCrossRef
90.
Krishna SG, Hart PA, DeWitt JM et al. EUS-guided confocal laser endomicroscopy: prediction of dysplasia in intraductal papillary mucinous neoplasms (with video). Gastrointest Endosc 2020;91:551-563.e5.PubMedCrossRef
91.
92.
Karia K, Waxman I, Konda VJ et al. Needle-based confocal endomicroscopy for pancreatic cysts: the current agreement in interpretation. Gastrointest Endosc 2016;83:924–927.PubMedCrossRef
93.
Krishna SG, Swanson B, Hart PA et al. Validation of diagnostic characteristics of needle based confocal laser endomicroscopy in differentiation of pancreatic cystic lesions. Endosc Int Open 2016;4:E1124–E1135.PubMedPubMedCentralCrossRef
94.
Krishna SG, Brugge WR, Dewitt JM et al. Needle-based confocal laser endomicroscopy for the diagnosis of pancreatic cystic lesions: an international external interobserver and intraobserver study (with videos). Gastrointest Endosc 2017;86:644-654.e2.PubMedCrossRef
95.
Nakai Y, Iwashita T, Park DH et al. Diagnosis of pancreatic cysts: EUS-guided, through-the-needle confocal laser-induced endomicroscopy and cystoscopy trial: DETECT study. Gastrointest Endosc 2015;81:1204–1214.PubMedCrossRef
96.
Eiterman A, Lahooti A, Krishna SG. Endosonographic diagnosis of advanced neoplasia in intraductal papillary mucinous neoplasms. World J Gastroenterol 2020;26:3201–3212.PubMedPubMedCentralCrossRef
97.
Cheesman AR, Zhu H, Liao X et al. Impact of EUS-guided microforceps biopsy sampling and needle-based confocal laser endomicroscopy on the diagnostic yield and clinical management of pancreatic cystic lesions. Gastrointest Endosc 2020;91:1095–1104.PubMedCrossRef
98.
Le Pen C, Palazzo L, Napoléon B. A health economic evaluation of needle-based confocal laser endomicroscopy for the diagnosis of pancreatic cysts. Endosc Int Open 2017;5:E987–E995.PubMedPubMedCentralCrossRef
99.
Sahora K, Ferrone CR, Brugge WR et al. Effects of comorbidities on outcomes of patients with intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2015;13:1816–1823.
100.
Kwok K, Chang J, Duan L et al. Competing risks for mortality in patients with asymptomatic pancreatic cystic neoplasms: implications for clinical management. Am J Gastroenterol 2017;112:1330–1336.PubMedCrossRef
101.
Kawakubo K, Tada M, Isayama H et al. Risk for mortality from causes other than pancreatic cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. Pancreas 2013;42:687–691.PubMedCrossRef
102.
Pergolini I, Sahora K, Ferrone CR et al. Long-term risk of pancreatic malignancy in patients with branch duct intraductal papillary mucinous neoplasm in a referral center. Gastroenterology 2017;153:1284-1294.e1.PubMedCrossRef
103.
Crippa S, Pezzilli R, Bissolati M et al. Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management. Am J Gastroenterol 2017;112:1153–1161.PubMedCrossRef
104.
Marchegiani G, Andrianello S, Pollini T et al. ‘Trivial’ cysts redefine the risk of cancer in presumed branch-duct intraductal papillary mucinous neoplasms of the pancreas: a potential target for follow-up discontinuation? Am J Gastroenterol 2019;114:1678–1684.PubMedCrossRef
105.
Moayyedi P, Weinberg DS, Schünemann H et al. Management of pancreatic cysts in an evidence-based world. Gastroenterology 2015;148:692–695.PubMedCrossRef
106.
107.
Schenck RJ, Miller FH, Keswani RN. The surveillance patterns of incidentally detected pancreatic cysts vary widely and infrequently adhere to guidelines. Pancreas 2019;48:883–887.PubMedCrossRef
108.
Lennon AM, Manos LL, Hruban RH et al. Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. Ann Surg Oncol 2014;21:3668–3674.PubMedPubMedCentralCrossRef
109.
Verma D, Kwok KK, Wu BU. Patient preferences for management of cystic neoplasms of the pancreas: a cross-sectional survey study. Pancreas 2017;46:352–357.PubMedCrossRef
110.
Choi JH, Lee SH, Choi YH et al. Clinical outcomes of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions compared with the natural course: a propensity score matching analysis. Ther Adv Gastroenterol 2018;11:175628481875992.CrossRef
111.
Moyer MT, Maranki JL, DeWitt JM. EUS-guided pancreatic cyst ablation: a clinical and technical review. Curr Gastroenterol Rep 2019;21:19.PubMedCrossRef
112.
Oh H-C, Brugge WR. EUS-guided pancreatic cyst ablation: a critical review (with video). Gastrointest Endosc 2013;77:526–533.PubMedCrossRef
113.
Teoh AY-B, Seo DW, Brugge W et al. Position statement on EUS-guided ablation of pancreatic cystic neoplasms from an international expert panel. Endosc Int Open. 2019;7:1064–1077.CrossRef
114.
Gan SI, Thompson CC, Lauwers GY et al. Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc 2005;61:746–752.PubMedCrossRef
115.
DeWitt J, McGreevy K, Schmidt CM et al. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc 2009;70:710–723.PubMedCrossRef
116.
DiMaio CJ, DeWitt JM, Brugge WR. Ablation of pancreatic cystic lesions: the use of multiple endoscopic ultrasound-guided ethanol lavage sessions. Pancreas 2011;40:664–668.PubMedCrossRef
117.
Caillol F, Poincloux L, Bories E et al. Ethanol lavage of 14 mucinous cysts of the pancreas: a retrospective study in two tertiary centers. Endosc Ultrasound 2012;1:48–52.PubMedPubMedCentralCrossRef
118.
Gómez V, Takahashi N, Levy MJ et al. EUS-guided ethanol lavage does not reliably ablate pancreatic cystic neoplasms (with video). Gastrointest Endosc 2016;83:914–920.PubMedCrossRef
119.
Park JK, Song BJ, Ryu JK et al. Clinical outcomes of endoscopic ultrasonography-guided pancreatic cyst ablation. Pancreas 2016;45:889–894.PubMedCrossRef
120.
Choi JH, Lee SH, Choi YH et al. Safety of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions: a single-center experience of 214 patients. Hepatobiliary Pancreat Dis Int HBPD INT 2019;18:562–568.PubMedCrossRef
121.
Choi J-H, Seo DW, Song TJ et al. Long-term outcomes after endoscopic ultrasound-guided ablation of pancreatic cysts. Endoscopy 2017;49:866–873.PubMedCrossRef
122.
Oh H-C, Seo DW, Song TJ et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology 2011;140:172–179.PubMedCrossRef
123.
Oh H-C, Seo DW, Kim SC et al. Septated cystic tumors of the pancreas: Is it possible to treat them by endoscopic ultrasonography-guided intervention? Scand J Gastroenterol 2009;44:242–247.PubMedCrossRef
124.
DeWitt JM, Al-Haddad M, Sherman S et al. Alterations in cyst fluid genetics following endoscopic ultrasound-guided pancreatic cyst ablation with ethanol and paclitaxel. Endoscopy 2014;46:457–464.PubMedCrossRef
125.
Oh H-C, Seo DW, Lee TY et al. New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc 2008;67:636–642.PubMedCrossRef
126.
Moyer MT, Dye CE, Sharzehi S et al. Is alcohol required for effective pancreatic cyst ablation? the prospective randomized CHARM trial pilot study. Endosc Int Open 2016;4:E603–E607.PubMedPubMedCentralCrossRef
127.
Kim KH, McGreevy K, La Fortune K et al. Sonographic and cyst fluid cytologic changes after EUS-guided pancreatic cyst ablation. Gastrointest Endosc 2017;85:1233–1242.PubMedCrossRef
128.
Moyer MT, Sharzehi S, Mathew A et al. The safety and efficacy of an alcohol-free pancreatic cyst ablation protocol. Gastroenterology 2017;153:1295–1303.PubMedCrossRef
129.
Attila T, Adsay V, Faigel DO. The efficacy and safety of endoscopic ultrasound-guided ablation of pancreatic cysts with alcohol and paclitaxel: a systematic review. Eur J Gastroenterol Hepatol 2019;31:1–9.PubMedCrossRef
130.
131.
Allen BC, Chen MY, Childs DD et al. Imaging-guided radiofrequency ablation of cystic renal neoplasms. AJR Am J Roentgenol 2013;200:1365–1369.PubMedCrossRef
132.
Yoon HM, Baek JH, Lee JH et al. Combination therapy consisting of ethanol and radiofrequency ablation for predominantly cystic thyroid nodules. AJNR Am J Neuroradiol 2014;35:582–586.PubMedPubMedCentralCrossRef
133.
Barthet M, Giovannini M, Lesavre N et al. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study. Endoscopy 2019;51:836–842.PubMedCrossRef
134.
Pai M, Habib N, Senturk H et al. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg 2015;7:52–59.PubMedPubMedCentralCrossRef
135.
136.
Metadata
Title
State-of-the-Art Update of Pancreatic Cysts
Authors
Andrew Canakis
Linda S. Lee
Publication date
12-08-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07084-1

Other articles of this Issue 5/2022

Digestive Diseases and Sciences 5/2022 Go to the issue

Review

Primary Bariatric Procedures

Original Article

Carbonic Anhydrases II, IX, and XII in Reflux Esophagitis

Review

Advanced EUS Imaging Techniques

Original Article

Inhibition of TLR7 and TLR9 Reduces Human Cholangiocarcinoma Cell Proliferation and Tumor Development

Review

Endoscopic Management of Barrett's Esophagus

Review

Artificial Intelligence in Endoscopy

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits